Breaking News Headlines Today

News from The Cancer Letter

Stay current with all the latest and breaking news from The Cancer Letter. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 115 of The Cancer Letter’s headlines and news stories over the past 3 months.

The Ground News media bias check for The Cancer Letter is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

The Cancer Letter’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about The Cancer Letter

Where is The Cancer Letter located?The Cancer Letter's Website The Cancer Letter's Twitter

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top The Cancer Letter News

Trump Administration · United States

Federal judge reverses rule that would have removed medical debt from credit reports

68% Center coverage: 144 sources

By Tami Luhby, CNN (CNN) — Americans’ unpaid medical bills will remain on their credit reports after a federal judge last week vacated a Biden-era Consumer Financial Protection Bureau (CFPB) rule that would have removed such debt. Judge Sean Jordan of the US District Court of Texas’ Eastern District found that the rule exceeded the bureau’s authority under the Fair Credit Reporting Act, agreeing with the arguments of two industry associations, w…See the Story

Donald Trump

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out - The Cancer Letter

The first large cancer screening/early detection initiative to be launched in 2025—the NCI-funded Vanguard study of multi-cancer detection tests—has started accruing patients through nine sites across the U.S. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/…United States · United States Read Article

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director His appointment came out of “proximity” to Makary and Bhattacharya - The Cancer Letter

In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site an…Rockville, Maryland · Rockville Read Article

City of Hope brings evidence-based approaches to integrative oncology - The Cancer Letter

The landscape of cancer care is evolving rapidly, with growing recognition that optimal patient outcomes require a whole-person care approach that goes beyond cytotoxic and targeted therapies. At City of Hope, innovative and holistic care is part of our culture and mission, making integrative oncology a natural fit with our national leadership in whole-person care. Through the Cherng Family Center for Integrative Oncology, we are pioneering a c…Duarte · Duarte Read Article

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts - The Cancer Letter

NCI announced that the paylines for R01 grants for established and new investigators are expected to drop to the 4th percentile—a historic low for the institute. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/register to read.The post FY25 paylines drop to…Donald Trump · Washington Read Article

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC - The Cancer Letter

In April, FDA Commissioner Marty Makary said that the presence of industry employees as members of FDA advisory committees “represents a cozy relationship” between FDA and the businesses it regulates. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/register …Rockville, Maryland · Rockville Read Article

Iowan to Lead American Cancer Society

The American Cancer Society and its advocacy affiliate the American Cancer Society Cancer Action Network announced Iowa State University alumnus Shane Jacobson as the new CEO of both organizations. He will begin this role August 12. Jacobson, who currently serves as CEO of the V Foundation for Cancer Research, will succeed Dr. Wayne A. I.…Atlanta, Georgia · Atlanta See the Story

News from The Cancer Letter

News from The Cancer Letter

Information about The Cancer Letter

Media Bias Ratings

Factuality

Ownership

Top The Cancer Letter News

Federal judge reverses rule that would have removed medical debt from credit reports

Trump Aims Tariff Double Whammy at Industries, Nations by Aug. 1

White House Touts Deal with Columbia as Critics Decry ‘Chilling’ Precedent

Blindspots

White House Touts Deal with Columbia as Critics Decry ‘Chilling’ Precedent

Letter: Budget Bill Will Hurt Inclusive Programs

Myeloma Drug's Comeback Nixed by FDA Panel

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out - The Cancer Letter

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director His appointment came out of “proximity” to Makary and Bhattacharya - The Cancer Letter

City of Hope brings evidence-based approaches to integrative oncology - The Cancer Letter

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts - The Cancer Letter

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC - The Cancer Letter

Iowan to Lead American Cancer Society

Similar News Topics

Topics Most Covered by The Cancer Letter

Sources Covering Similar Topics

Breaking News Topics Related to The Cancer Letter

Information about The Cancer Letter

Media Bias Ratings

Factuality

Ownership

Letter: Budget Bill Will Hurt Inclusive Programs

Myeloma Drug's Comeback Nixed by FDA Panel

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out - The Cancer Letter

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director His appointment came out of “proximity” to Makary and Bhattacharya - The Cancer Letter

City of Hope brings evidence-based approaches to integrative oncology - The Cancer Letter

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts - The Cancer Letter

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC - The Cancer Letter

Iowan to Lead American Cancer Society